{
  "@context": "aku-v2",
  "@type": "concept",
  "@id": "vascular:carotid:recurrent-stenosis",
  "metadata": {
    "version": "1.0.0",
    "created": "2026-01-05T12:56:56.000Z",
    "contributors": ["copilot"],
    "status": "validated",
    "reviewedBy": [],
    "confidence": 0.92
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/pathology/carotid-disease",
    "type": "pathology",
    "difficulty": "advanced",
    "importance": "high",
    "isNativeDomain": true
  },
  "content": {
    "title": "Recurrent Carotid Stenosis",
    "description": "Stenosis developing after prior carotid endarterectomy or stenting, with distinct pathophysiology and management considerations compared to primary disease.",
    "definition": "Recurrent carotid stenosis is narrowing at a previously treated carotid site. Early recurrence (<2 years) is typically due to myointimal hyperplasia (smooth, low embolization risk), while late recurrence (>2 years) represents new atherosclerosis (higher stroke risk). Management depends on symptom status and timing of recurrence.",
    "clinical_features": {
      "pathophysiology_by_timing": [
        "Early (<2 years): Myointimal hyperplasia (neointimal proliferation)",
        "Late (>2 years): Recurrent atherosclerosis",
        "Early lesions: Smooth, less prone to embolization",
        "Late lesions: Ulcerated, higher stroke risk"
      ],
      "incidence": [
        "Hemodynamically significant recurrence: 5-10%",
        "Higher after primary closure vs patch closure",
        "Higher after eversion CEA in some studies",
        "Stent restenosis: 5-10% at 2 years"
      ],
      "evaluation": [
        "Duplex surveillance post-CEA recommended",
        "Timing: 30 days, 6 months, then annually",
        "CTA/MRA for surgical planning if significant",
        "Assess for symptoms - asymptomatic may be observed"
      ],
      "management": [
        "Asymptomatic myointimal hyperplasia: Often observe",
        "Symptomatic or progressive: Consider intervention",
        "CAS often preferred for post-CEA recurrence",
        "Redo CEA technically challenging (scar, cranial nerves)",
        "Patch angioplasty if redo CEA performed"
      ]
    },
    "codes": {
      "snomed_ct": ["441509002"],
      "icd_10": ["I97.89"]
    },
    "relationships": {
      "skos:broader": ["vascular:carotid:pathology"],
      "skos:related": ["vascular:cea", "vascular:cas"],
      "skos:narrower": []
    },
    "cross_domain_references": [],
    "pedagogy": {
      "learning_objectives": [
        "Distinguish early vs late recurrent stenosis",
        "Understand pathophysiologic differences",
        "Apply surveillance protocols",
        "Select appropriate treatment"
      ],
      "clinical_pearls": [
        "Early recurrence (myointimal hyperplasia) often benign - low stroke risk",
        "Late recurrence (atherosclerosis) behaves like primary disease",
        "CAS preferred for redo to avoid cranial nerve injury from scarring",
        "Patch closure reduces recurrence compared to primary closure",
        "Lifetime surveillance is required after CEA"
      ],
      "board_yield": "HIGH"
    }
  }
}
